CN1886132A - 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物 - Google Patents
用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物 Download PDFInfo
- Publication number
- CN1886132A CN1886132A CNA200480035459XA CN200480035459A CN1886132A CN 1886132 A CN1886132 A CN 1886132A CN A200480035459X A CNA200480035459X A CN A200480035459XA CN 200480035459 A CN200480035459 A CN 200480035459A CN 1886132 A CN1886132 A CN 1886132A
- Authority
- CN
- China
- Prior art keywords
- integer
- chemical compound
- diastereomer
- enantiomer
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104484 | 2003-12-02 | ||
| EP03104484.5 | 2003-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1886132A true CN1886132A (zh) | 2006-12-27 |
Family
ID=34639309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA200480035459XA Pending CN1886132A (zh) | 2003-12-02 | 2004-12-01 | 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物 |
Country Status (22)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115246774A (zh) * | 2021-04-27 | 2022-10-28 | 南昌弘益科技有限公司 | 一类新型双羰基类阿魏酸衍生物 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE437637T1 (de) | 2001-05-02 | 2009-08-15 | Nitromed Inc | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren |
| WO2007090733A1 (en) * | 2006-02-06 | 2007-08-16 | Nicox S.A. | Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists |
| CA2641501A1 (en) | 2006-02-06 | 2007-08-16 | Nicox S.A. | Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
| WO2008112287A1 (en) | 2007-03-12 | 2008-09-18 | Nektar Therapeutics | Oligomer-beta blocker conjugates |
| JP2010527401A (ja) | 2007-05-14 | 2010-08-12 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 抗菌材料および被膜 |
| US8062653B2 (en) * | 2009-02-18 | 2011-11-22 | Bezwada Biomedical, Llc | Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| US11420995B2 (en) | 2017-03-03 | 2022-08-23 | Synovo Gmbh | Anti-infective and anti-inflammatory compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
| DE3443998A1 (de) * | 1984-12-01 | 1986-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE3512627A1 (de) * | 1985-04-06 | 1986-10-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel |
| ES2065291B1 (es) * | 1993-07-30 | 1995-10-01 | Prodesfarma Sa | "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente" |
| US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1311923B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1314184B1 (it) * | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
| EP1385509A4 (en) * | 2001-04-02 | 2004-06-30 | Smithkline Beecham Corp | TREATMENT METHOD |
| DE60222131D1 (de) * | 2001-05-28 | 2007-10-11 | Chemtech Res Inc | Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung |
| ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
-
2004
- 2004-12-01 DK DK04803434T patent/DK1691804T3/da active
- 2004-12-01 AR ARP040104485A patent/AR047732A1/es not_active Application Discontinuation
- 2004-12-01 PL PL380065A patent/PL380065A1/pl not_active Application Discontinuation
- 2004-12-01 PL PL04803434T patent/PL1691804T3/pl unknown
- 2004-12-01 KR KR1020067010491A patent/KR20060120677A/ko not_active Withdrawn
- 2004-12-01 PT PT04803434T patent/PT1691804E/pt unknown
- 2004-12-01 RU RU2006119528/04A patent/RU2006119528A/ru not_active Application Discontinuation
- 2004-12-01 AT AT04803434T patent/ATE358478T1/de not_active IP Right Cessation
- 2004-12-01 DE DE602004005748T patent/DE602004005748T2/de not_active Expired - Lifetime
- 2004-12-01 WO PCT/EP2004/013683 patent/WO2005053685A1/en not_active Ceased
- 2004-12-01 BR BRPI0416584-5A patent/BRPI0416584A/pt not_active IP Right Cessation
- 2004-12-01 HR HR20070283T patent/HRP20070283T3/xx unknown
- 2004-12-01 AU AU2004294297A patent/AU2004294297A1/en not_active Abandoned
- 2004-12-01 EP EP04803434A patent/EP1691804B1/en not_active Expired - Lifetime
- 2004-12-01 SI SI200430328T patent/SI1691804T1/sl unknown
- 2004-12-01 JP JP2006541892A patent/JP2007513114A/ja active Pending
- 2004-12-01 US US10/577,912 patent/US7825263B2/en not_active Expired - Fee Related
- 2004-12-01 CN CNA200480035459XA patent/CN1886132A/zh active Pending
- 2004-12-01 ES ES04803434T patent/ES2285549T3/es not_active Expired - Lifetime
- 2004-12-01 CA CA002548129A patent/CA2548129A1/en not_active Abandoned
-
2006
- 2006-03-31 ZA ZA200604458A patent/ZA200604458B/xx unknown
- 2006-04-11 IL IL174959A patent/IL174959A0/en unknown
- 2006-06-30 NO NO20063057A patent/NO20063057L/no not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115246774A (zh) * | 2021-04-27 | 2022-10-28 | 南昌弘益科技有限公司 | 一类新型双羰基类阿魏酸衍生物 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20070072854A1 (en) | 2007-03-29 |
| ZA200604458B (en) | 2007-04-25 |
| DK1691804T3 (da) | 2007-07-16 |
| PL380065A1 (pl) | 2006-12-11 |
| EP1691804A1 (en) | 2006-08-23 |
| HRP20070283T3 (en) | 2007-11-30 |
| DE602004005748D1 (de) | 2007-05-16 |
| KR20060120677A (ko) | 2006-11-27 |
| US7825263B2 (en) | 2010-11-02 |
| WO2005053685A1 (en) | 2005-06-16 |
| ES2285549T3 (es) | 2007-11-16 |
| SI1691804T1 (sl) | 2007-10-31 |
| JP2007513114A (ja) | 2007-05-24 |
| IL174959A0 (en) | 2006-08-20 |
| BRPI0416584A (pt) | 2007-01-30 |
| PT1691804E (pt) | 2007-07-04 |
| AR047732A1 (es) | 2006-02-15 |
| ATE358478T1 (de) | 2007-04-15 |
| AU2004294297A1 (en) | 2005-06-16 |
| PL1691804T3 (pl) | 2007-08-31 |
| DE602004005748T2 (de) | 2007-12-27 |
| NO20063057L (no) | 2006-06-30 |
| RU2006119528A (ru) | 2008-01-10 |
| EP1691804B1 (en) | 2007-04-04 |
| CA2548129A1 (en) | 2005-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1024667C (zh) | 取代的氨甲基四氢化萘和取化氨甲基氢化苯并吡喃及其盐制备方法 | |
| CN1144799C (zh) | N-(亚氨基甲基)胺衍生物,其制备方法,其作为药物的用途以及含有该化合物的药物组合物 | |
| CN1538967A (zh) | 杂环化合物和以其为有效成分的抗肿瘤药 | |
| CN1090281A (zh) | 具有抗糖尿病和抗肥胖症性质的噁唑烷衍生物,它们的制备和它们在治疗方面的用途 | |
| CN1109054A (zh) | 噁唑烷-2-酮衍生物 | |
| CN1906159A (zh) | 前列腺素硝基氧衍生物 | |
| CN1035178C (zh) | 芳酰胺衍生物 | |
| CN1246315C (zh) | 氨基烷基苯甲酰基-苯并呋喃或苯并噻吩类,它们的制备方法与含有它们的组合物 | |
| CN1203587A (zh) | 新的杂环衍生物及其医药用途 | |
| CN1077954A (zh) | 新的苯并吡喃衍生物 | |
| CN1032751C (zh) | 噻唑烷化合物,其制备及其治疗用途 | |
| CN86104787A (zh) | 制备聚-4-氨基吡咯-2-甲酰胺基衍生物的方法 | |
| CN1423637A (zh) | 新的取代的三环化合物 | |
| CN1147469C (zh) | 带有芳香族含氮杂环的新型脲衍生物 | |
| CN1027536C (zh) | 4,5,6,7-四氢化苯并咪唑衍生物制备方法 | |
| CN1071665A (zh) | 唑烷酮衍生物 | |
| CN1254334A (zh) | 新颖的对苯二甲酰胺衍生物 | |
| CN1167707C (zh) | 作为细胞粘连抑制剂的单糖的2,3-o-异亚丙基衍生物 | |
| CN85101425A (zh) | 带有次苯基的斯伯格埃林有关化合物及其制备方法 | |
| CN1590379A (zh) | 新的杂环肟化合物、它们的制备方法和含有它们的药物组合物 | |
| CN1708491A (zh) | N-苯并间二氧杂环戊烯基、n-苯并二噁烷基和n-苯并二氧杂䓬基芳基甲酰胺衍生物以及包含它们的药物组合物 | |
| CN1183907C (zh) | 新的咪唑啉化合物、其制备方法和含有它们的药物组合物 | |
| CN1662519A (zh) | 新化合物及其作为甘氨酸转运抑制剂的用途 | |
| CN1047860A (zh) | 丁烯酸衍生物 | |
| CN1148378C (zh) | 15-脱氧精胍林类似物、其制备方法及其治疗应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1102002 Country of ref document: HK |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1102002 Country of ref document: HK |